May 25, 2016 / 5:07 PM / a year ago

BRIEF-Biosyent signs distribution agreement for new cardiovascular products

1 Min Read

May 25 (Reuters) - Biosyent Inc:

* Biosyent signs exclusive distribution agreement for two new cardiovascular products

* Intends to submit dossier seeking marketing approval of products to Health Canada in 2016

* Forecasts that the new products will add approximately CAD $20 million to overall revenue of company when they reach "peak sales" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below